Surviving childhood cancer: A special series on the successes and challenges after “Cure”
Treatment adherence and 6-mercaptopurine metabolites
Achieving cure for early stage pediatric Hodgkin disease with minimal morbidity: Are we there yet?
Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy
Barriers to follow-up care of survivors in the United States and the United Kingdom
Long-term follow-up of childhood cancer survivors: Future directions for clinical care and research
Long-term follow-up of pediatric cancer survivors: Education, surveillance, and screening
Models of care for survivors of childhood cancer
Delivering long-term follow-up care to pediatric cancer survivors: Transitional care issues
Importance of clinical and epidemiological research in defining the long-term clinical care of pediatric cancer survivors
Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: A report of POG study 9296
How low is too low? Use of cluster analysis to define low levels of mercaptopurine metabolites
Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): A Children's Oncology Group Report
Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: A Pediatric Oncology Group (POG) study
Hyperplastic perilobar nephroblastomatosis: Long-term survival of 52 patients
Pulmonary function abnormalities in children treated with whole lung irradiation
Risk factors for diabetes insipidus in langerhans cell histiocytosis
Measurement of cerebrovascular flow reserve in pediatric patients with sickle cell disease
Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide
Chronic granulomatous disease in Latin American patients: Clinical spectrum and molecular genetics
Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment
Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation
Phase II study of gemcitabine in children with relapsed leukemia
Management of hyperplastic nephroblastomatosis
Neuroblastoma stage 4S with 123I-MIBG-positive bone marrow involvement
Spleen and lung involvement by Acinetobacter calcoaceticus bacteremia mimicking deep fungal infection in a child with acute non-lymphoblastic leukemia
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis 1